Literature DB >> 7090995

Myocardial injury in infants with congenital heart disease: evaluation by creatine kinase MB isoenzyme analysis.

R J Boucek, A G Kasselberg, R C Boerth, M D Parrish, T P Graham.   

Abstract

Total creatine kinase (CK) and the myocardial isoenzyme CK MB activity were prospectively determined in 282 children hospitalized for cardiac catheterization and evaluation for suspected congenital cardiac abnormalities and compared with a hospitalized control group of children without such abnormalities. The percent CK MB and CK MB activity were abnormally elevated in symptomatic children with a large left to right shunt due either to a large ventricular septal defect (n = 22; p less than 0.001) or to complete atrioventricular canal (n = 10; p less than 0.001). Serum CK MB activity and percent CK MB were significantly related to the size of the shunt and the age of presentation with clinical symptoms of congestive heart failure in infants with a ventricular septal defect. CK MB activity was abnormally elevated in infants with symptomatic coarctation of the aorta, either with or without a ventricular septal defect (n = 15; p less than 0.001), and in infants with symptomatic aortic stenosis (n = 4; p less than 0.02). In contrast, CK MB activity was normal in asymptomatic children with coarctation of the aorta (n = 14) or aortic stenosis (n = 8) despite comparable systolic pressure gradients. CK MB activity and percent CK MB were abnormally elevated in those children with the cyanotic congenital cardiac abnormalities of either transposition of the great arteries (n = 32; p less than 0.001) or right ventricular outflow tract obstruction (n = 31; p less than 0.001). These results suggest that children with congenital cardiac abnormalities may have significant myocardial cell injury and release of CK MB that may be detected by the determination of serum CK MB activity. Cell injury may be secondary to arterial desaturation or acute pressure-volume overload, or both, as manifested by clinical symptoms of heart failure and measured hemodynamic variables.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7090995     DOI: 10.1016/0002-9149(82)90018-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Abnormalities of right ventricular long axis function after atrial repair of transposition of the great arteries.

Authors:  G P Derrick; M Josen; M Vogel; M Y Henein; E A Shinebourne; A N Redington
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

2.  Right ventricular function 10 years after the Mustard operation for transposition of the great arteries: analysis of size, shape, and wall motion.

Authors:  A N Redington; M L Rigby; P Oldershaw; D G Gibson; E A Shinebourne
Journal:  Br Heart J       Date:  1989-12

3.  Cardiac biomarkers and acute kidney injury after cardiac surgery.

Authors:  Emily M Bucholz; Richard P Whitlock; Michael Zappitelli; Prasad Devarajan; John Eikelboom; Amit X Garg; Heather Thiessen Philbrook; Philip J Devereaux; Catherine D Krawczeski; Peter Kavsak; Colleen Shortt; Chirag R Parikh
Journal:  Pediatrics       Date:  2015-03-09       Impact factor: 7.124

4.  Long-Term Morpholino Oligomers in Hexose Elicits Long-Lasting Therapeutic Improvements in mdx Mice.

Authors:  Gang Han; Caorui Lin; Hanhan Ning; Xianjun Gao; HaiFang Yin
Journal:  Mol Ther Nucleic Acids       Date:  2018-06-21       Impact factor: 8.886

5.  Oral delivery of xenon for cardiovascular protection.

Authors:  Xing Yin; Melanie R Moody; Valeria Hebert; Melvin E Klegerman; Yong-Jian Geng; Tammy R Dugas; David D McPherson; Hyunggun Kim; Shao-Ling Huang
Journal:  Sci Rep       Date:  2019-10-01       Impact factor: 4.379

6.  Myocardial Injury in Children with Unoperated Congenital Heart Diseases.

Authors:  Mohamed O Hafez; Saed M Morsy; Ragab A Mahfoz; Ahmed R Ali
Journal:  Cardiol Res Pract       Date:  2015-11-16       Impact factor: 1.866

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.